SlateStone Wealth’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218K Sell
1,993
-11,803
-86% -$1.68M 0.02% 279
2025
Q4
$2.29M Buy
13,796
+1,052
+8% +$176K 0.19% 99
2025
Q3
$2.5M Buy
12,744
+160
+1% +$26.3K 0.22% 99
2025
Q2
$1.14M Buy
12,584
+2,989
+31% +$236K 0.11% 143
2025
Q1
$573K Sell
9,595
-8,805
-48% -$815K 0.06% 194
2024
Q4
$2.44M Buy
18,400
+2,400
+15% +$225K 0.24% 91
2024
Q3
$838K Buy
+16,000
New +$751K 0.08% 169

Other funds holding ALAB

SlateStone Wealth's ALAB Position: Q1 2026 in Review

SlateStone Wealth reduced its Astera Labs (ALAB) stake by 86% in Q1 2026, selling an estimated $1.68M and leaving 1,993 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #279.

SlateStone Wealth first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.5M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • SlateStone Wealth held 1,993 shares of Astera Labs worth $218K as of Q1 2026.
  • SlateStone Wealth sold 11,803 Astera Labs shares in Q1 2026, an estimated $1.68M.
  • Astera Labs made up 0.02% of SlateStone Wealth's portfolio in Q1 2026, its #279 holding.
  • SlateStone Wealth first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • SlateStone Wealth's Astera Labs position peaked at $2.5M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on SlateStone Wealth's 13F filing for Q1 2026, filed 14 May 2026.